⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30481593 | 0.79 | — | — | |
| SCHEMBL27791197 | 0.78 | — | — | |
| SCHEMBL4661605 | 0.78 | — | — | |
| SCHEMBL8051975 | 0.78 | — | — | |
| SCHEMBL532604 | 0.75 | HSP90AA1 (0.35) | — | |
| SCHEMBL1444665 | 0.75 | HSP90AA1 (0.40) | — | |
| SCHEMBL14678180 | 0.75 | HSP90AA1 (0.40) | — | |
| SCHEMBL1012306 | 0.75 | — | — | |
| SCHEMBL24250864 | 0.74 | — | — | |
| SCHEMBL1666852 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2307 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220145295-A1 | ENZYMATIC RNA SYNTHESIS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-05-12 | — | — | US | claimed |
| EP-3864151-A2 | ENZYMATIC RNA SYNTHESIS | President and Fellows of Harvard College (US) | 2021-08-18 | — | — | EP | claimed |
| CN-113195720-A | Enzymatic RNA synthesis | 哈佛大学的校长及成员们 | 2021-07-30 | — | — | CN | claimed |
| US-20150211004-A1 | RNAI-BASED THERAPIES FOR CARDIOMYOPATHIES, MUSCULAR DYSTROPHIES AND LAMINOPATHIES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-07-30 | — | — | US | claimed |
| EP-2838541-A1 | RNAI-BASED THERAPIES FOR CARDIOMYOPATHIES, MUSCULAR DYSTROPHIES AND LAMINOPATHIES | Agency For Science, Technology And Research (SG) | 2015-02-25 | — | — | EP | claimed |
| WO-2013158046-A1 | RNAI-BASED THERAPIES FOR CARDIOMYOPATHIES, MUSCULAR DYSTROPHIES AND LAMINOPATHIES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-10-24 | — | — | WO | claimed |
| US-7179914-B2 | Process for the production of 4-alkylpyrimidine | DEGUSSA AG (DE) | 2007-02-20 | — | — | US | claimed |
| US-20040225126-A1 | Process for the production of 4-alkylpyrimidine | DEGUSSA AG (DE) | 2004-11-11 | — | — | US | claimed |
| US-20240240187-A1 | SIRNA TARGETING TMPRSS6 FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS | SILENCE THERAPEUTICS GMBH (DE) | 2024-07-18 | — | — | US | disclosed |
| EP-4400168-A2 | ANTISENSE NUCLEIC ACIDS | Nippon Shinyaku Co., Ltd. (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-20240229035-A1 | ANTIVIRAL NUCLEIC ACID | NIPPON SHINYAKU CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228577-A1 | Programmed Cell Death Protein 1 (PD1) Compositions and Methods for Cell-Based Therapy | INTELLIA THERAPEUTICS, INC. (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240229041-A2 | NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF CNNM4 IN A CELL | ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE (ES) | 2024-07-11 | — | — | US | disclosed |
| EP-3071547-B1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS INC (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-1999004819-A1 | LIPOSOMAL COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACID CATALYSTS | INEX PHARMACEUTICALS CORPORATION (CA) | 1999-02-04 | — | — | WO | disclosed |
| EP-0886641-A2 | SYNTHESIS OF METHOXY NUCLEOSIDES AND ENZYMATIC NUCLEIC ACID MOLECULES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1998-12-30 | — | — | EP | disclosed |
| WO-1998050530-A2 | ENZYMATIC NUCLEIC ACIDS: SYNTHESIS, SELECTION AND USE | RIBOZYME PHARMACEUTICALS, INC. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998043993-A2 | NUCLEIC ACID CATALYSTS | YALE UNIVERSITY (US) | 1998-10-08 | — | — | WO | disclosed |
| WO-1998028317-A2 | SYNTHESIS OF NUCLEOSIDES AND POLYNUCLEOTIDES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1997026270-A2 | SYNTHESIS OF METHOXY NUCLEOSIDES AND ENZYMATIC NUCLEIC ACID MOLECULES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1997-07-24 | — | — | WO | disclosed |